The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), poses several challenges to clinicians, due to its …

Introduction: The aim of this study was to analyze biomarkers that might predict the severity
and progression of the SARS-CoV-2 infection, both in the acute phase and after recovery …

Recent study showed that around 80% of coronavirus disease-19 (COVID-19) patients are
moderate cases who will recover with or without conventional treatment, while the remaining …

Background Most of the explanatory and prognostic models of COVID-19 lack of a
comprehensive assessment of the wide COVID-19 spectrum of abnormalities. The aim of …

With the availability of COVID-19-related clinical data, healthcare researchers can now
explore the potential of computational technologies such as artificial intelligence (AI) and …

COVID-19 is a severe respiratory disease caused by SARS-CoV-2, a novel human
coronavirus. Patients infected with SARS-CoV-2 exhibit heterogeneous symptoms that pose …

The current pandemic due to the fast spreading of SARS-CoV-2 infection has caused severe
impairment in health, social, economic, scientific, and medical sectors across the globe …

Despite the association of prevalent health conditions with coronavirus disease 2019
(COVID-19) severity, the disease-modifying biomolecules and their pathogenetic …

The COVID-19 pandemic has caused huge socio-economic losses and continues to threat
humans worldwide. With more than 4.5 million deaths and more than 221 million confirmed …

Dear Editor, The diverse clinical manifestations of COVID-19 are substantially modulated by
host immune responses, emphasising the need for investigating the initial Transcriptional …